Phase I clinical trial with ametantrone (NSC-287513)
- 1 July 1981
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 17 (7) , 775-779
- https://doi.org/10.1016/0014-2964(81)90233-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- PHARMACOLOGICAL DISPOSITION OF 1,4-BIS(2-[(2-HYDROXYETHYL)AMINO]-ETHYLAMINO)-9,10-ANTHRACENEDIONE DIACETATE IN THE DOG1980
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesJournal of Medicinal Chemistry, 1979
- Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activityJournal of Medicinal Chemistry, 1979
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- EXPERIMENTAL ANTI-TUMOR ACTIVITY OF AMINOANTHRAQUINONES1979
- EFFECTS OF 9,10-ANTHRACENEDIONE, 1,4-BIS[[2-[(2-HYDROXYETHYL)AMINO]-ETHYL]AMINO]-DIACETATE ON CELL-SURVIVAL AND CELL-CYCLE PROGRESSION IN CULTURED MAMMALIAN-CELLS1979